Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Literature Review of COPD 2008

호흡기내과 의사를 위한 COPD 리뷰

  • Lee, Sang Yeub (Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Korea University)
  • 이상엽 (고려대학교 의과대학 내과학교실)
  • Received : 2009.05.29
  • Accepted : 2009.05.30
  • Published : 2009.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Snider GL. Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Am Rev Respir Dis 1989;140:S3-8 https://doi.org/10.1164/ajrccm/140.3_Pt_2.S3
  2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2007 [Internet]. [place unknown]: Global Initiative for Chronic Obstructive Lung Disease (GOLD); c2009. Available from: http://www.goldcopd.com
  3. Decramer M, Rutten-van Mölken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet 2005;365:1552-60 https://doi.org/10.1016/S0140-6736(05)66456-2
  4. Pauwels RA, Löfdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European respiratory society study on chronic obstructive pulmonary disease. N Engl J Med 1999;340:1948-53 https://doi.org/10.1056/NEJM199906243402503
  5. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000;320:1297-303 https://doi.org/10.1136/bmj.320.7245.1297
  6. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008;178:332-8 https://doi.org/10.1164/rccm.200712-1869OC
  7. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89 https://doi.org/10.1056/NEJMoa063070
  8. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the lung health study. JAMA 1994;272:1497-505 https://doi.org/10.1001/jama.272.19.1497
  9. Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000;343:1902-9 https://doi.org/10.1056/NEJM200012283432601